- Practical outcomes of the renin-angiotensin-aldosterone genes polymorphisms studies in clinical practice.Publication without faculty affiliation
- Antagonists of the renin-angiotensin-aldosterone system2011 | First Faculty of Medicine
- The role of the renin-angiotensin-aldosterone systemin blood pressure regulation and pathogenesis of essential hypertension2002 | First Faculty of Medicine
- The treatment of arterial hypertension in patient with myocardial infaction in recent history, the percutaneous coronary intervention is just the beginning2021 | First Faculty of Medicine
- Renin-Angiotensin-Aldosterone System: Friend or Foe-The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions2021 | Faculty of Medicine in Hradec Králové
- Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment2005 | Second Faculty of Medicine
- Renal and cardiovascularconsequences of albuminuria2011 | First Faculty of Medicine
- Effect of melatonin on the renin-angiotensin-aldosterone system in L-NAME-induced hypertension2018 | Faculty of Medicine in Hradec Králové
- Sacubitril/valsartan - new dual inhibitor of neprilysin and angiotensin II receptors2016 | First Faculty of Medicine
- Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontanenously Hypertensive Rats: Different Interaction with the Renin-Angiotensin-Aldosterone System2022 | Faculty of Medicine in Hradec Králové
- The Effect of Adrenalectomy on Exercise Response of the Renin-Angiotensin-Aldosterone System and Exercise Tolerance in Primary Aldosteronism2018 | First Faculty of Medicine
- Effect of Renin-Angiotensin-Aldosteron System Gene Polymorphism on Restenosis Development in Patients Treated with Percutaneous Coronary InterventionPublication without faculty affiliation
- ACE-inhibitors and mortality in hypertension: metaanalysis of radnomised clinical trials of renin-angiotensin-aldosterone inhibitors2012 | First Faculty of Medicine
- Blockade of the renin-angiotensin-aldosteron system (RAAS) in secondary cardiovascular prevention2009 | First Faculty of Medicine
- Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension2018 | Faculty of Medicine in Hradec Králové
- Aliskiren in the treatment of cardiovascular disease. Preliminary resulst of ALTITUDE study.2012 | First Faculty of Medicine
- Angiotensin converting enzyme inhibitors and angiotensin II AT1 receptor antagonists (sartans) used in the secondary prevention of cardiovascular events, comparison of basic data2010 | Third Faculty of Medicine
- Angiotensin converting enzyme inhibitors in nephrology2019 | First Faculty of Medicine
- The aldosterone antagonists2011 | First Faculty of Medicine
- Deleterious effects of hyperactivity of the renin-angiotensin system and hypertension on the course of chemotherapy-induced heart failure after doxorubicin administration: A study in ren-2 transgenic rat2020 | Second Faculty of Medicine
- Low-renin hypertension resistant to treatment2009 | First Faculty of Medicine
- The therapy of uveitis2018 | First Faculty of Medicine
- Aliskiren/hydrochlorothiazide - fixed combination2010 | Third Faculty of Medicine
- Newer possibilities of slowing the development of chronic kidney disease and the role of dapagliflozin2022 | First Faculty of Medicine
- AT1 blockers - comparability with ACE inhibitors2017 | First Faculty of Medicine
- Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial2016 | Third Faculty of Medicine
- The exaggerated salt-sensitive response in hypertensive transgenic rats (TGR mRen-2) fostered by a normotensive female2019 | Central Library of Charles University
- Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial2022 | Publication without faculty affiliation
- Obesity and COVID-19: A Perspective from the European Association for the Study of Obesity on Immunological Perturbations, Therapeutic Challenges, and Opportunities in Obesity2020 | Faculty of Medicine in Pilsen
- Left ventricle remodeling in men with moderate to severe volume-dependent hypertension2012 | First Faculty of Medicine